Skip to search formSkip to main contentSkip to account menu

Recombinant OX40 Ligand

Known as: OX40 ligand, OX40L 
A recombinant agent, which is chemically identical to or similar to the endogenous protein Fas ligand OX40, a member of the tumor necrosis factor… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Radiotherapy remains effective at treating primary, early-stage tumors, however it produces nominal results in late-stage and… 
2017
2017
Targeting regulatory T cells The immunosuppressive actions of regulatory T (Treg) cells have limited the success of cancer… 
2017
2017
Immunologic responses to cancer involve complex interactions of cells within the tumor microenvironment (TME). These interactions… 
2017
2017
The breakthrough discoveries of checkpoint inhibitors in the field of tumor immunology have driven the clinical success of… 
2013
2013
We used B6.MRL-Faslpr/J(B6.Fas) mouse model of systemic lupus erythematosus(SLE) to investigate the expression of OX40 and OX40L… 
2010
2010
10622 Background: Antigens expressed by melanoma cells (MAA) and recognized by T lymphocytes have been used in various… 
2006
2006
Objective To investigate glucocorticoid effects on the expressions of MHC-Ⅱand OX40L in activated microglia cell line N9.Methods… 
2005
2005
The nucleotide sequence and the heavy chain and amino acid sequences containing the light chain of monoclonal antibody encoding…